Aurobindo Pharma: Closure of Trading Window | Value Research

Aurobindo Pharma: Closure of Trading Window

This is to inform that as per the Companys Internal Code of Conduct to Regulate Monitor and Report Trading by Designated Persons the Trading Window for dealing in the securities of the Company would remain closed for all designated persons including promoters directors key managerial personnel employees connected persons and their immediate relatives with effect from October 1 2022 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the second quarter ending on September 30 2022.The date of Board Meeting for declaration of the financial results of the Company for the second quarter ending on September 30 2022 will be intimated in due course.

Click here to view PDF


Other Categories